Saturday, September 04, 2010

Home

Clinical Trials
       Adult ADHD
       Adult Bipolar
       Alzheimers
       Alzheimers-TV
       Anxiety
       Bowel Dysfunction
       Bowel Dysfunction-TV
       Diabetes
       Diabetes-TV
       Fibromyalgia-TV
       Hot Flashes
       Hot Flashes-TV
       Hypertension
       Hypertension-TV
       Influenza
       Influenza-TV
       Insomnia
       Insomnia-TV
       Osteoarthritis
       Low Back Pain-TV
       Pediatric ADHD
       Pediatric Bipolar
       Pediatric Depression
       Pediatric Migraine
       Senior depression
       Schizophrenia-TV
       Senior depression-TV
       Treatment Resitant Depression

About NWCRC
       FAQ About Clinical Trials
       Participant Feedback
       Center Overview
          Abstracts, Book Reviews and Other Publications 
          Academic Memberships and Related Activities
          Dr. Khan' Curriculum Vitae 
          Clinical and Academic Experience
          Grants, Awards & Research Experience
          Journal Reviewer 
          Manuscripts In Press
          Publications
             DST Results in Nonpsychotic Depressed Outpatients
             Onset of response in relation to outcome in...
             Characteristics of Placebo Response during Long...
             Chronicity of Depressive Episode in Relation to...
             Venlafaxine in Depressed Outpatients

Contact Us
       Privacy Officer Contact Form
       Web Administrator Contact

6/84
Sandoz Award for superior academic achievement, Department of Psychiatry, University of Connecticut
 
9/84 - 2/90
Clinical psychopharmacology sub-investigator in depressive disorders. Psychiatric Research Unit, Harborview Medical Center and University of Washington (PI - D. Dunner, MD)
 
3/85
Principal Investigator, Biomedical Research Support Grant from University of Washington for the study of treatment response to various antidepressants and placebo
 
8/87
Travel fellowship from the American College of Neuropsychopharmacology (ACNP)
 
10/88
Principal Investigator, ECT vs. pharmacotherapy in psychotic depression (R01 application (approved, not funded)
 
1/89 - 12/89
Co-Investigator, Sleep changes in Early Alzheimers Disease (PI- Patricia Prinz, PhD, MHR01-33688)
 
3/91 - 10/91
Principal Investigator, The Washington Institute for Mental Illness, Research and Training Grant for TRH in ECT and ECS
 
1/92 - 12/92
Principal Investigator, The Alcohol and Drug Abuse Institute, University of Washington, Grant for TRH in cognitively impaired alcoholics
 
6/94
Principal Investigator, Treatment of Depression Using Low-level Electrical Current or Alternating Magnetic Fields (patent filed)
 
3/90 - Present
Principal Investigator, Phase I, II, III and IV Psychopharmacology Studies in depression, treatment resistant depression, generalized anxiety disorder, insomnia, bipolar mood disorder, schizophrenia, Alzheimer’s disease, migraine, irritable bowel syndrome, post traumatic stress disroder, social anxiety disorder, attention deficit/hyperactivity disorder, female hypoactive sexual desire disorder, pediatric depression, pediatric bipolar mood disorder, pediatric attention deficit/hyperactivity disorder, pain, obsessive compulsive disorder, geriatric depression, geriatric generalized anxiety disorder 
 
3/01 - Present
Extramural Reviewer, SBIR proposals, Ad Hoc committees, NIMH
 
3/2005
Thomson Essential Science Indicators recognizing two publications (#66 and #81) receiving top 1% of citations between 2000 and 2004 suggesting extraordinary career accomplishment
 
11/2006 - Present
Member of the Board American College of Clinical Psychopharmacology

 

 

 

 



 

 

CAPTCHA image
Enter the code shown above

2009 Best of Business Award

Copyright © 1999-2010 Northwest Clinical Research Center. * Trademarks are the property of their respective owners. All rights reserved.